Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Hologic ( (HOLX) ) is now available.
Hologic, Inc. has expanded its Board of Directors by appointing Martin Madaus, effective December 6, 2024. With over 30 years in diagnostics and life sciences, Madaus brings a wealth of experience from his roles at Carlyle Group and as CEO of Ortho Clinical Diagnostics and Millipore Corporation. This strategic addition aligns with Hologic’s commitment to enhancing leadership for future growth in women’s health technology.
See more insights into HOLX stock on TipRanks’ Stock Analysis page.
